Log in to save to my catalogue

Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analys...

Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analys...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2f5f530e7eb84a92a8527ce7881ceec6

Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analysis

About this item

Full title

Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analysis

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical and translational science, 2022-10, Vol.15 (10), p.2403-2436

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Taxane‐based chemotherapy regimens are used as first‐line treatment for breast cancer. Neurotoxicity, mainly taxane‐induced peripheral neuropathy (TIPN), remains the most important dose‐limiting adverse event. Multiple genes may be associated with TIPN; however, the strength and direction of the association remain unclear. For this reason, we syste...

Alternative Titles

Full title

Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2f5f530e7eb84a92a8527ce7881ceec6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2f5f530e7eb84a92a8527ce7881ceec6

Other Identifiers

ISSN

1752-8054

E-ISSN

1752-8062

DOI

10.1111/cts.13370

How to access this item